Chronic renal failure (CRF) is a devastating medical, social and economic problem for patients and their families (1). The availability and quality of dialysis programs largely depends on the prevailing economic conditions, the political-social structure, overall health care facilities, and the health care funding strategies of various countries. Key factors in the prognosis of patients with CRF include the moment in which they are referred to a nephrologist and the quality of pre-dialysis care. Once CRF is detected the necessary measures have to be taken to dialysis progression, to prevent uremic complications and to modify the potential comorbid factors. Renal replacement therapy (RRT) includes maintenance hemodialysis, continuous ambulatory peritoneal dialysis and renal transplantation. Vascular access (VA) is essential for chronic HD and is considered to be both a lifeline and an Achilles' heel, as it ameliorates many of the clinical manifestations of renal failure and postpones an otherwise imminent fatal situation. Therefore, early VA creation is considered an important step in the management of patients with CRF and this applies in both developing and in developed countries. The concept of arteriovenous fistula (AVF) creation, although it appears simple, is associated with significant problems, particularly in developing countries like India. The major factor of concern in developing countries remains the cost of RRT (2). In India the management of end-stage renal disease (ESRD) is largely guided by economic considerations, and in the absence of health insurance plans, <10% of all patients receive dialysis treatments (3, 4) . To make the situation worse, the majority of these patients either dies or is forced to abandon treatment because of cost constraints within the first 3 months. No doubt, in considering and comparing the cost of various RRTs, VA surgery (AVF) seems to be the cheapest option. In reality, there is very little effort required from the treating physician in providing treatment for patients. Most of the time, patients are also resistant to undergo fistula surgery, providing they remain free from uremic symptoms. Ideally, each patient starting on chronic HD would have a permanent VA ready for use at the time of the first treatment, but due to the lack of awareness, most patients are referred very late in the process. No center in India follows the guidelines (DOQI, AVS, CARI etc) recommended for the creation of an arteriovenous VA before the start of chronic HD therapy. There is a significant delay in referral for access surgery; as a result, many patients are admitted with already damaged superficial and central veins. Patients with very high creatinine (Cr) levels are invariably subjected to the placement of central lines. As we observed, 82% of our patients referred for AVF have Cr levels >6 mg/dl and 40% already have a neck line. In most of the setup in India, the delay in diagnosis and the failure to institute measures to slow the progression of renal failure result in a predominantly young ESRD population. These are the patients susceptible to repeated phlebotomies and intravenous catheters; and therefore, minimizing the options of creating an AVF during the initial admission. In addition, there is a significant increase in the diabetic population, and diabetic nephropathy is the most common cause of ESRD between the ages of 40 and 60 yrs (4) in India; 35-40% of our patients are diabetics. Progressive disease and calcified distal vessels often preclude the primary option of a radiocephalic AVF at the wrist. Irrespective of this, some centers still consider repeatedly trying futile attempts over the wrist. To get an ideal VA, proper clinical and radiological assessment is a necessity. This seems to be a very casual business in India, as many inexperienced personnel are involved in providing these services.
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Many times it is left to a junior surgeon, as a first step in learning vascular anastomosis. Surgeons feel offended in posting these cases as main cases on their lists, so invariably these fragile patients get their chance towards the end of the day when the experienced staff is away. The concept of preoperative assessment is rare in many institutes. It is a serious concern, as most of our patients have damaged venous vasculatures. These kinds of patients require an expert, who is experienced and aware of all the possible access surgeries. The numbers are quite low in India, as very few people are focused on this subject. The other area where we are still in infancy is the insufficient development of endovascular techniques that can save dysfunctional and thrombosed fistulas, which are not salvageable by conventional surgical techniques. This could be due to a lack of motivation as well as to insufficient training. Infections like methicillin-resistant staphylococcus aureus (MRSA) and hepatitis C virus (HCV) are also prevalent, which increases patient morbidity as well as leading to an unsatisfactory surgical result. HCV infection is now a major cause of hepatitis during HD after the control for hepatitis B following vaccination and isolation measures (5) . Neck line infection is another serious concern in our setup. Leaving aside the doctor-related factors which have been discussed above, coming to patient-related factors, significant drop-out during follow-up is a serious issue after access surgery, and various reports have highlighted the incidence of this as being as high as 60% (4). This simply reflects the lack of communication amongst the treating team, financial constraints and the lack of facilities. Only 14% of hospitals have nephrology care units with 600-650 qualified nephrologists. There are approximately 1000 dialysis stations, >70% are in the private sector;
and therefore, most of the population living in remote rural areas do not have access to it (4) . India is considered as the "world capital of diabetes mellitus", and it is sad that there is absolutely no concern for these patients when they are planned for access surgery. This results in not only failure but we also lose them in the follow-up, as they do not return for further access surgery. The situation is tragic, as with a population of more than one billion, we do not have any registries, guidelines, programs or special clinics for VA.
In conclusion, although hemodialysis has transformed the gloomy outcome of chronic renal failure, we face the important challenge of an adequate vascular access. This is particularly true when we consider that patients who were once consigned to death from renal failure are now routinely maintained on hemodialysis with a quite reasonable life span. Indeed, the set of operations known collectively as Dialysis Access Surgery is the cornerstone of haemodialysis. The goal of access surgery is to provide an adequate permanent, trouble free vascular access, essential for long term management of renal failure. But such goal cannot be always fulfilled in reality. Though looks simple, it is associated with a significant number of problems, particularly in developing countries.
